AlzeCure Pharma AB (FRA:AC6) Forward Dividend Yield %: 0.00% (As of Jul. 13, 2026)


FRA:AC6 AlzeCure Pharma AB FRA:AC6
33 GF Score
Price €0.53
! 1 Warning Sign
View Full Analysis

What is AlzeCure Pharma AB Forward Dividend Yield %?

AlzeCure Pharma AB FRA:AC6 -6.97% 33 Forward Dividend Yield % is 0.00% as of Jul. 13, 2026. GuruFocus rates FRA:AC6 with a GF Score™ of 33/100. The stock has 1 warning sign investors should review. Among 148 Biotechnology companies, AlzeCure Pharma AB ranks worse than 675675% on this metric.

As of today (2026-07-13), the Forward Annual Dividend Yield of AlzeCure Pharma AB is 0.00%.

As of today (2026-07-13), the Trailing Annual Dividend Yield of AlzeCure Pharma AB is 0.00%.

FRA:AC6's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.275
* Ranked among companies with meaningful Forward Dividend Yield % only.

AlzeCure Pharma AB's Dividends per Share for the three months ended in Mar. 2026 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

AlzeCure Pharma AB  (FRA:AC6) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

AlzeCure Pharma AB Forward Dividend Yield % Related Terms

FRA:AC6 vs VRTX, REGN, ALNY: Forward Dividend Yield % Comparison

For the Biotechnology subindustry, AlzeCure Pharma AB's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AlzeCure Pharma AB Forward Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AlzeCure Pharma AB's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where AlzeCure Pharma AB's Forward Dividend Yield % falls into.


FRA:AC6
33GF Score
AlzeCure Pharma AB FRA:AC6
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AlzeCure Pharma AB Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

What does a Forward Dividend Yield % of 0.00% mean?
AlzeCure Pharma AB (FRA:AC6) has a Forward Dividend Yield % of 0.00% as of Jul. 13, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on AlzeCure Pharma AB and its competitors. According to the industry distribution chart, AlzeCure Pharma AB ranks #999999 out of 148 companies in the Biotechnology industry.
Is AlzeCure Pharma AB's Forward Dividend Yield % too high?
AlzeCure Pharma AB's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, AlzeCure Pharma AB ranks #999999 out of 148 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, AlzeCure Pharma AB has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does AlzeCure Pharma AB's Forward Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, AlzeCure Pharma AB ranks #999999 out of 148 companies for Forward Dividend Yield %. This places AlzeCure Pharma AB in the lower half of its industry. The industry median Forward Dividend Yield % is 1.28. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Biotechnology company?
The median Forward Dividend Yield % among Biotechnology companies is 1.28, based on 148 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on AlzeCure Pharma AB and its competitors. For the Biotechnology industry, the median Forward Dividend Yield % is 1.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AlzeCure Pharma AB's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AlzeCure Pharma AB stock overvalued right now?
AlzeCure Pharma AB (FRA:AC6) has a current Forward Dividend Yield % of 0.00%. The current Forward Dividend Yield % is 0.00%. AlzeCure Pharma AB's overall GF Score™ is 33/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For AlzeCure Pharma AB (FRA:AC6), the current Forward Dividend Yield % is 0.00% as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AlzeCure Pharma AB Business Description

Other Exchanges ALZCUR:Sweden
Address Halsovagen 7, Huddinge, SWE, SE 141 57
AlzeCure Pharma AB is a Swedish pharmaceutical company engaged in drug research with a primary focus on Alzheimer's disease. The company develops several drugs within its three research platforms, NeuroRestore, Alzstatin, and Painless. The company's drug candidates include: ACD440, which is in the clinical development phase for the treatment of neuropathic pain, ACD856, ACD857, and ACD680 for the treatment of Alzheimer's disease, and ACD137 for the treatment of severe pain in conditions such as osteoarthritis.
33GF Score

Get the complete analysis for FRA:AC6

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.53
Price